Back
Arbutus Biopharma Stock Price Chart
Sponsored
ABUS
Sponsored
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
27
ABUS
Arbutus Biopharma
Last Price:
$3.20
Seasonality Move:
21.65%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.
Arbutus Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.41 | Sell |
20-day SMA: | 3.5 | Sell |
50-day SMA: | 3.71 | Sell |
200-day SMA: | 3.44 | Sell |
8-day EMA: | 3.37 | Sell |
20-day EMA: | 3.49 | Sell |
50-day EMA: | 3.63 | Sell |
200-day EMA: | 3.44 | Sell |
Arbutus Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 33.79 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.35 - 3.65) | Sell |
Bollinger Bands (100): | (3.53 - 4.11) | Sell |
Arbutus Biopharma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arbutus Biopharma Stock
Is Arbutus Biopharma Stock a Buy?
-
Arbutus Biopharma share price is 3.21 while ABUS 8-day simple moving average is 3.41, which is a Sell signal.
-
The stock price of ABUS is 3.21 while Arbutus Biopharma 20-day SMA is 3.50, which makes it a Sell.
-
Arbutus Biopharma 50-day simple moving average is 3.71 while ABUS share price is 3.21, making it a Sell technically.
-
ABUS stock price is 3.21 and Arbutus Biopharma 200-day simple moving average is 3.44, creating a Sell signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
27
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy or a Sell?
-
Arbutus Biopharma stock is rated a SellThe current Arbutus Biopharma [ABUS] share price is $3.21. The Score for ABUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Stock Info
Market Cap:
608.3M
Price in USD:
3.21
Share Volume:
3M
Arbutus Biopharma 52-Week Range
52-Week High:
4.73
52-Week Low:
2.21
Sell
27
Arbutus Biopharma (ABUS)
is a Sell
Arbutus Biopharma Share Price Forecast
-
What is the Arbutus Biopharma stock price today?The Arbutus Biopharma stock price is 3.21 USD today.
-
Will ABUS stock go up or go down?Arbutus Biopharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Arbutus Biopharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma is overvalued.
Is Arbutus Biopharma Stock a Buy?
-
Arbutus Biopharma share price is 3.21 while ABUS 8-day exponential moving average is 3.37, which is a Sell signal.
-
The stock price of ABUS is 3.21 while Arbutus Biopharma 20-day EMA is 3.49, which makes it a Sell.
-
Arbutus Biopharma 50-day exponential moving average is 3.63 while ABUS share price is 3.21, making it a Sell technically.
-
ABUS stock price is 3.21 and Arbutus Biopharma 200-day simple moving average is 3.44, creating a Sell signal.
Fundamental Analysis of Arbutus Biopharma
Is Arbutus Biopharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Technical Analysis of Arbutus Biopharma
Should I short Arbutus Biopharma stock?
-
ABUS Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Arbutus Biopharma is a Sell
-
Arbutus Biopharma Relative Strength Index (RSI) is 33.79, which suggest Arbutus Biopharma is oversold
-
The Bollinger Bands (25) for Arbutus Biopharma is (3.35 - 3.65), which suggest Arbutus Biopharma is a Sell
-
The Bollinger Bands (100) for Arbutus Biopharma is (3.53 - 4.11), which suggest Arbutus Biopharma is a Sell
* Arbutus Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.